Seattle Genetics, Inc. : SGEN

SGEN

Stock Data

$228.74

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

All SGEN Articles

84 Articles

Paul Ausick | Mar 13, 2023 at 7:33 AM EDT

Before the Bell: Banks Break Bad, Pfizer Buys Seagen

The U.S. Treasury Department and the Federal Reserve took decisive steps to prevent the collapse of two banks from turning…

Paul Ausick | Feb 27, 2023 at 7:34 AM EST

Before the Bell: Buffett’s America, Bed Bath & Beyond’s New Life, and a Big Drug Deal

Warren Buffett's annual letter, Bed Bath & Beyond's latest lease on life and a possible pharma deal worth more than…

Lee Jackson | Feb 17, 2023 at 8:56 AM EST

Friday’s Top Analyst Upgrades and Downgrades: Activision Blizzard, Analog Devices, Baker Hughes, Coinbase, Devon Energy, Expedia, Marathon Oil, Nvidia, Roku, Shopify, Twilio and More

Friday's top analyst upgrades and downgrades included Activision Blizzard, Analog Devices, Baker Hughes, Coinbase Global, Devon Energy, Electronic Arts, Expedia,…

Lee Jackson | Feb 7, 2023 at 8:44 AM EST

Tuesday’s Top Analyst Upgrades and Downgrades: ADM, Boeing, Dow, Netflix, Splunk, Spotify, T-Mobile, Walmart and More

Tuesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Boeing, Dow, LyondellBasell Industries, Netflix, Splunk, Spotify Technology, T-Mobile,…

Lee Jackson | Feb 7, 2023 at 7:14 AM EST

5 Goldman Sachs Conviction List Stock Pick Winners With 50% to 75% Upside Potential

These five top Goldman Sachs Conviction List stock picks have the largest upside to the firm's target prices. Growth investors…

Lee Jackson | Nov 22, 2022 at 8:42 AM EST

Tuesday’s Top Analyst Upgrades and Downgrades: Cheniere Energy, Cutera, Datadog, Disney, Intel, Mobileye Global, NetEase, Salesforce, Take-Two Interactive, Workday and More

Tuesday's top analyst upgrades and downgrades included Cheniere Energy, Disney, Intel, Salesforce, Toyota, and Wynn Resorts.

Paul Ausick | Jan 31, 2022 at 10:36 AM EST

Monday Morning’s 5 Tech Stock Movers Include Netflix and Tesla

Two tech stocks that have taken some lumps in recent days received a boost Monday from analyst upgrades.

Jon C. Ogg | Sep 22, 2020 at 8:59 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More

Tuesday’s top analyst upgrades and downgrades included Alibaba, Amazon.com, Apple, Carvana, Illumina, NextEra Energy, Nikola, Shake Shack, Teladoc Health and…

Jon C. Ogg | Sep 15, 2020 at 8:54 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Citigroup, Facebook, Lennar, Netflix, NextEra, Nvidia, Nike, Pinterest, Roku, Snap and More

Tuesday's top analyst upgrades and downgrades included Alphabet, Citigroup, Facebook, Lennar, Netflix, NextEra, Nvidia, Nike, Pinterest, Roku and Snap.

Jon C. Ogg | Jul 31, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: Alexion, Allscripts, Alphabet, Amazon, Apple, Baidu, Comcast, EA, Ford, Facebook and More

Friday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Allscripts Healthcare Solutions, Alphabet, Amazon.com, Apple, Baidu, Comcast, Electronic Arts, Ford…

Lee Jackson | Jul 27, 2020 at 7:21 AM EDT

5 Goldman Sachs Conviction Buy Stocks With the Most Upside

We screened the Goldman Sachs Conviction List for the stocks that have the biggest upside to the firm's price targets…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Jon C. Ogg | Jul 24, 2020 at 9:14 AM EDT

Top Analyst Upgrades and Downgrades: AGNC, Annaly, Arbutus, Blackstone, Chevron, Enphase, Exxon, GM, Intel, Tesla, Skyworks and More

Friday's top analyst upgrades and downgrades included AGNC Investment, Annaly Capital Management, Arbutus Biopharma, Blackstone, Chevron, Enphase Energy, Exxon Mobil,…

Jon C. Ogg | Jun 30, 2020 at 9:13 AM EDT

Top Analyst Upgrades and Downgrades: ANGI, Carnival, Chegg, Clorox, Crocs, Dish, Etsy, Intercept, Micron, Okta, Seattle Genetics, Spotify, Square, 2U and More

Tuesday's top analyst upgrades and downgrades included ANGI Homeservices, Carnival, Chegg, Clorox, Crocs, Dish Network, Etsy, Intercept Pharmaceuticals, Micron Technology,…

Lee Jackson | Apr 27, 2020 at 7:15 AM EDT

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies…

1 2 3 … 6

Seattle Genetics, Inc. : SGEN

SGEN

$228.74

All SGEN Articles

Before the Bell: Banks Break Bad, Pfizer Buys Seagen

Before the Bell: Buffett’s America, Bed Bath & Beyond’s New Life, and a Big Drug Deal

Friday’s Top Analyst Upgrades and Downgrades: Activision Blizzard, Analog Devices, Baker Hughes, Coinbase, Devon Energy, Expedia, Marathon Oil, Nvidia, Roku, Shopify, Twilio and More

Tuesday’s Top Analyst Upgrades and Downgrades: ADM, Boeing, Dow, Netflix, Splunk, Spotify, T-Mobile, Walmart and More

5 Goldman Sachs Conviction List Stock Pick Winners With 50% to 75% Upside Potential

Tuesday’s Top Analyst Upgrades and Downgrades: Cheniere Energy, Cutera, Datadog, Disney, Intel, Mobileye Global, NetEase, Salesforce, Take-Two Interactive, Workday and More

Monday Morning’s 5 Tech Stock Movers Include Netflix and Tesla

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More

Top Analyst Upgrades and Downgrades: Alphabet, Citigroup, Facebook, Lennar, Netflix, NextEra, Nvidia, Nike, Pinterest, Roku, Snap and More

Top Analyst Upgrades and Downgrades: Alexion, Allscripts, Alphabet, Amazon, Apple, Baidu, Comcast, EA, Ford, Facebook and More

5 Goldman Sachs Conviction Buy Stocks With the Most Upside

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Top Analyst Upgrades and Downgrades: AGNC, Annaly, Arbutus, Blackstone, Chevron, Enphase, Exxon, GM, Intel, Tesla, Skyworks and More

Top Analyst Upgrades and Downgrades: ANGI, Carnival, Chegg, Clorox, Crocs, Dish, Etsy, Intercept, Micron, Okta, Seattle Genetics, Spotify, Square, 2U and More

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Seattle Genetics, Inc. : SGEN

SGEN

$228.74

All SGEN Articles

Before the Bell: Banks Break Bad, Pfizer Buys Seagen

Before the Bell: Buffett’s America, Bed Bath & Beyond’s New Life, and a Big Drug Deal

Friday’s Top Analyst Upgrades and Downgrades: Activision Blizzard, Analog Devices, Baker Hughes, Coinbase, Devon Energy, Expedia, Marathon Oil, Nvidia, Roku, Shopify, Twilio and More

Tuesday’s Top Analyst Upgrades and Downgrades: ADM, Boeing, Dow, Netflix, Splunk, Spotify, T-Mobile, Walmart and More

5 Goldman Sachs Conviction List Stock Pick Winners With 50% to 75% Upside Potential

Tuesday’s Top Analyst Upgrades and Downgrades: Cheniere Energy, Cutera, Datadog, Disney, Intel, Mobileye Global, NetEase, Salesforce, Take-Two Interactive, Workday and More

Monday Morning’s 5 Tech Stock Movers Include Netflix and Tesla

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More

Top Analyst Upgrades and Downgrades: Alphabet, Citigroup, Facebook, Lennar, Netflix, NextEra, Nvidia, Nike, Pinterest, Roku, Snap and More

Top Analyst Upgrades and Downgrades: Alexion, Allscripts, Alphabet, Amazon, Apple, Baidu, Comcast, EA, Ford, Facebook and More

5 Goldman Sachs Conviction Buy Stocks With the Most Upside

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Top Analyst Upgrades and Downgrades: AGNC, Annaly, Arbutus, Blackstone, Chevron, Enphase, Exxon, GM, Intel, Tesla, Skyworks and More

Top Analyst Upgrades and Downgrades: ANGI, Carnival, Chegg, Clorox, Crocs, Dish, Etsy, Intercept, Micron, Okta, Seattle Genetics, Spotify, Square, 2U and More

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026